HAT probe with adjustable switching characteristic and application thereof
By designing the polydeoxythymidine sequence and raised secondary structure of the HAT probe, combined with the DNAzyme activation mechanism and AuNP signal enrichment, the problems of false positives and signal leakage of nucleic acid probes in complex samples were solved, and high sensitivity and stable biosensing effect were achieved.
Patent Information
- Application Number
- CN202610071204.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-20
- Publication Date
- 2026-05-29
AI Technical Summary
Existing nucleic acid probes are prone to non-specific binding in complex biological samples, leading to false positives. Furthermore, the signal amplification process is prone to leakage, resulting in poor system robustness and a lack of external control capabilities. It is difficult to achieve high sensitivity and low background signal without affecting the target binding ability.
A HAT probe containing a polydeoxythymidine sequence and a raised secondary structure was designed to inhibit Cas12a trans-cleavage through steric hindrance, and to achieve fine regulation of Cas12a activity by combining DNAzyme activation mechanism and AuNP signal enrichment.
It achieves high signal-to-noise ratio biosensing, maintains high sensitivity and stability in complex samples, has a detection limit of up to 2.05×10-15M, and features low background and fast response capabilities.